| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.JU.0000154356.76027.4F |
| P698 | PubMed publication ID | 15821546 |
| P50 | author | Vincenzo Mirone | Q4013405 |
| Ferdinando Fusco | Q37834817 | ||
| Fabrizio Iacono | Q46595493 | ||
| P2093 | author name string | Giuseppe Manno | |
| Pasquale Somma | |||
| Renato Giannella | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1673-1676 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Histological alterations in cavernous tissue after radical prostatectomy | |
| P478 | volume | 173 |
| Q52651482 | A Novel Noninvasive Ultrasound Vibro-elastography Technique for Assessing Patients With Erectile Dysfunction and Peyronie Disease. |
| Q33928449 | A novel method to establish a rat ED model using internal iliac artery ligation combined with hyperlipidemia |
| Q53116648 | A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer. |
| Q64060640 | Administration of Adipose Derived Mesenchymal Stem Cells and Platelet Lysate in Erectile Dysfunction: A Single Center Pilot Study |
| Q59048530 | Advances in Stem Cell Therapy for Erectile Dysfunction |
| Q48343644 | Antioxidative mechanism of Lycium barbarum polysaccharides promotes repair and regeneration following cavernous nerve injury |
| Q45030921 | Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo |
| Q46987652 | Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection |
| Q34165055 | Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction. |
| Q35643372 | Current penile-rehabilitation strategies: Clinical evidence |
| Q47155631 | Dickkopf2 rescues erectile function by enhancing penile neurovascular regeneration in a mouse model of cavernous nerve injury |
| Q49441713 | Dipyridamole reduces penile apoptosis in a rat model of post-prostatectomy erectile dysfunction |
| Q38004124 | Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? |
| Q80826261 | Does androgen suppression plus radiation therapy lead to changes in penile length in prostate cancer patients? |
| Q45347452 | Does penile rehabilitation have a role in the treatment of erectile dysfunction following radical prostatectomy? |
| Q46947485 | Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections |
| Q36905474 | Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience |
| Q46738229 | Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. |
| Q99566086 | Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy |
| Q38415580 | Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia |
| Q57457740 | Effects of a high energy density diet in the "corpus cavernosum" of mice |
| Q91686847 | Effects of tadalafil to prevent injury on corpus cavernosum after vascular or nervous peri-prostatic bundle injury. Experimental model in rats |
| Q43783613 | Electrocautery-induced cavernous nerve injury in rats that mimics radical prostatectomy in humans |
| Q93016381 | Erectile Dysfunction: A Primer for in Office Management |
| Q36421042 | Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management |
| Q41896807 | Erectile dysfunction in robotic radical prostatectomy: Outcomes and management |
| Q38634621 | Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis |
| Q37905577 | Erectile preservation following radical prostatectomy |
| Q38774607 | Erection rehabilitation following prostatectomy--current strategies and future directions |
| Q84978588 | Experimental model of human corpus cavernosum smooth muscle relaxation |
| Q33572824 | Fibrotic protein expression profiles in penile tissue of patients with erectile dysfunction |
| Q47650710 | Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study |
| Q53122857 | Irbesartan promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective long-term analysis. |
| Q38201403 | Is there a rationale for penile rehabilitation following radical prostatectomy? |
| Q46991340 | Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. |
| Q49585624 | Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies |
| Q53062423 | Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. |
| Q38662843 | Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? |
| Q33682118 | Neural influences on sonic hedgehog and apoptosis in the rat penis |
| Q41874434 | Neuronal nitric oxide signaling regulates erection recovery after cavernous nerve injury |
| Q36405336 | Neurotrophic Effect of Adipose Tissue-Derived Stem Cells on Erectile Function Recovery by Pigment Epithelium-Derived Factor Secretion in a Rat Model of Cavernous Nerve Injury |
| Q42516819 | Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function |
| Q27027583 | Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors |
| Q39816838 | Outcome of penile prosthesis implantation: are malleable prostheses an appropriate treatment option in patients with erectile dysfunction caused by prior radical surgery? |
| Q53757607 | Penile Rehabilitation Strategies Among Prostate Cancer Survivors. |
| Q37306884 | Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve |
| Q51134530 | Penile rehabilitation after pelvic cancer surgery. |
| Q26773762 | Penile rehabilitation after radical prostatectomy: does it work? |
| Q79456683 | Penile rehabilitation after radical prostatectomy: important therapy or wishful thinking? |
| Q38119268 | Penile rehabilitation after radical prostatectomy: what the evidence really says |
| Q36993690 | Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy |
| Q37417114 | Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art. |
| Q38191882 | Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction |
| Q37623097 | Penile shortening after radical prostatectomy and Peyronie's surgery |
| Q37060766 | Periprostatic implantation of neural differentiated mesenchymal stem cells restores cavernous nerve injury-mediated erectile dysfunction |
| Q26773724 | Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors |
| Q46683159 | Predictive factors for return of erectile function in robotic radical prostatectomy: case series from a single centre. |
| Q38634616 | Preliminary results of a new tool to evaluate cavernous body fibrosis following radical prostatectomy: penile elastography |
| Q26773619 | Prevention and management of post prostatectomy erectile dysfunction |
| Q53103047 | Prospective analysis of penile length changes after radical prostatectomy. |
| Q53173082 | Protective effect of annexin-A1 against irreversible damage to cavernous tissue after cavernous nerve injury in the rat. |
| Q33281555 | Proteomic analysis of rat penile tissue in a model of erectile dysfunction after radical prostatectomy |
| Q34502071 | Reversion of penile fibrosis: Current information and a new horizon. |
| Q88596912 | S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction |
| Q36555652 | Sexual function after surgery for prostate or bladder cancer |
| Q92150232 | Sildenafil in postprostatectomy erectile dysfunction (perspective) |
| Q36798340 | Sonic hedgehog delivery from self-assembled nanofiber hydrogels reduces the fibrotic response in models of erectile dysfunction |
| Q33415666 | Sonic hedgehog, apoptosis, and the penis |
| Q35737480 | Stem cell therapy for erectile dysfunction: a critical review |
| Q38148781 | Stem-cell therapy for erectile dysfunction. |
| Q47366168 | Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy |
| Q34485718 | Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED |
| Q90520802 | The Combined Use of Stem Cells and Platelet Lysate Plasma for the Treatment of Erectile Dysfunction: A Pilot Study-6 Months Results |
| Q39067832 | The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review |
| Q28583330 | The role of hedgehog-interacting protein in maintaining cavernous nerve integrity and adult penile morphology |
| Q37395766 | The role of vacuum erection devices in penile rehabilitation after radical prostatectomy |
| Q52875108 | Transplantation of Human Urine-Derived Stem Cells Transfected with Pigment Epithelium-Derived Factor to Protect Erectile Function in a Rat Model of Cavernous Nerve Injury. |
| Q35019624 | Transplantation of muscle-derived stem cells into the corpus cavernosum restores erectile function in a rat model of cavernous nerve injury |
| Q38630432 | Treatments for fibrosis of the corpora cavernosa |
| Q35348909 | Use of nanoparticles to monitor human mesenchymal stem cells transplanted into penile cavernosum of rats with erectile dysfunction |
| Q40412849 | Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats. |
| Q46392230 | Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. |
| Q87333423 | [Conservative therapy of erectile dysfunction] |
| Q82740535 | [Erectile rehabilitation after radical prostatectomy] |
| Q82740503 | [Sexual dysfunction after radical prostatectomy] |
Search more.